Shao-Lee Lin
EVP, Head of R&D and CSO, Horizon Therapeutics Public Ltd Co.
Companies
- Cue Biopharma, Inc.Board member May 7, 2026 to now1
- Cue Biopharma, Inc.Chief executive officer May 7, 2026 to now1
- ACELYRIN, Inc.Board member May 4, 2023 to now2
- ACELYRIN, Inc.Chief executive officer May 4, 2023 to now2
- Surrozen, Inc./DEBoard member Aug 16, 2021 to now3
- Third Harmonic Bio, Inc.Board member Sep 14, 2022 to Oct 27, 20224
- Principia Biopharma (United States)Board member Apr 18, 2019 to Sep 28, 20205
- Horizon Therapeutics Public Ltd CoEVP, Head of R&D and CSO Jan 5, 2018 to Jan 23, 20206
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Cue Biopharma, Inc. CUE705,995 shares7$11.9M at $16.81Aug 13, 2026
- ACELYRIN, Inc.1,582,444 shares8Apr 3, 2024
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 13, 2026Sold 10,460 shares at $29.48 of Cue Biopharma, Inc.7
- Aug 13, 2026Sold 2,375 shares at $28.11 of Cue Biopharma, Inc.7
- Aug 13, 2026Sold 5,423 shares at $27.19 of Cue Biopharma, Inc.7
- Aug 12, 2026Sold 5,775 shares at $27.75 of Cue Biopharma, Inc.7
- Aug 12, 2026Sold 34,225 shares at $26.99 of Cue Biopharma, Inc.7
- Aug 12, 2026Exercised options 109,179 shares of Cue Biopharma, Inc.7
- Jul 9, 2026Granted 327,537 shares of Cue Biopharma, Inc.9
- May 3, 2026Granted 327,537 shares of Cue Biopharma, Inc.10
- Apr 1, 2024Sold 9,961 shares at $6.63 of ACELYRIN, Inc.8
- Feb 20, 2024Sold 15,701 shares at $7.60 of ACELYRIN, Inc.11
- Jan 2, 2024Sold 10,691 shares at $7.41 of ACELYRIN, Inc.12
- Oct 4, 2023Other 132,236 shares of ACELYRIN, Inc.13
- Oct 4, 2023Other 1,161,747 shares of ACELYRIN, Inc.13
- Aug 16, 2023Granted 842,400 shares of ACELYRIN, Inc.14
- May 9, 2023Other 5,070 shares of ACELYRIN, Inc.15
- May 9, 2023Other 5,070 shares of ACELYRIN, Inc.15
- May 9, 2023Other 349,898 shares of ACELYRIN, Inc.15
- May 9, 2023Other 349,898 shares of ACELYRIN, Inc.15
- May 9, 2023Other 354,969 shares of ACELYRIN, Inc.15
- May 9, 2023Other 354,969 shares of ACELYRIN, Inc.15
- May 9, 2023Other 354,969 shares of ACELYRIN, Inc.15
- May 9, 2023Other 354,969 shares of ACELYRIN, Inc.15
- May 9, 2023Other 677,813 shares of ACELYRIN, Inc.15
- May 9, 2023Other 677,813 shares of ACELYRIN, Inc.15
- May 9, 2023Shares withheld for tax 337,179 shares at $24.69 of ACELYRIN, Inc.15
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCue Biopharma, Inc., Board member
- 2SEC EDGARACELYRIN, Inc., Board member
- 3SEC EDGARSurrozen, Inc./DE, Board member
- 4
- 5
- 6
- 7
- 8
- 9SEC EDGARForm 4 filed Jul 10, 2026
- 10SEC EDGARForm 4 filed May 7, 2026
- 11SEC EDGARForm 4 filed Feb 22, 2024
- 12SEC EDGARForm 4 filed Jan 4, 2024
- 13SEC EDGARForm 4 filed Oct 6, 2023
- 14SEC EDGARForm 4 filed Aug 18, 2023
- 15SEC EDGARForm 4 filed May 11, 2023